Stock IQV IQVIA HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Real-time Estimate Cboe BZX
Other stock markets
 10:03:06 2024-04-18 am EDT 		5-day change 1st Jan Change
227.3 USD +0.02% Intraday chart for Iqvia Holdings Inc. -4.85% -2.12%
Apr. 17 Declaration of Voting Results by IQVIA Holdings CI
Apr. 10 Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Declaration of Voting Results by IQVIA Holdings
CI
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
BU
Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US
MT
Iqvia, Salesforce Collaborate to Accelerate Life Sciences Cloud Development
MT
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
BU
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
CI
Acrux, TruPharma Launch Dapsone 5% Gel in US
MT
Dr. Reddy's Laboratories Signs Deal to Distribute Sanofi's Vaccine Brands
MT
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
RE
Transcript : IQVIA Holdings Inc. - Special Call
Transcript : IQVIA Holdings Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:30 AM
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
BU
Iqvia Holdings Insider Sold Shares Worth $3,494,034, According to a Recent SEC Filing
MT
Iqvia Holdings Insider Sold Shares Worth $7,936,193, According to a Recent SEC Filing
MT
Iqvia Holdings Insider Sold Shares Worth $2,153,176, According to a Recent SEC Filing
MT
Transcript : IQVIA Holdings Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 09:30 AM
Truist Securities Raises IQVIA Holdings Price Target to $297 From $286, Maintains Buy Rating
MT
Leerink Partners Starts Coverage on IQVIA With Outperform Rating, $290 Price Target
MT
IQVIA Publishes its 2023 Environmental, Social and Governance Report
BU
John Chevedden Submits a Shareholder Proposal to IQVIA Holdings
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IQV Stock
  4. News Iqvia Holdings Inc.